---
home: true
icon: home
title: Home
heroImage: /icci.png # https://theme-hope-assets.vuejs.press/logo.svg
bgImage: https://theme-hope-assets.vuejs.press/bg/6-light.svg
bgImageDark: https://theme-hope-assets.vuejs.press/bg/6-dark.svg
bgImageStyle:
  background-attachment: fixed
heroText: International Congress of Cancer Immunotherapy
tagline: June 1-3,2024 │ Shanghai,China
actions:
  - text: Join us
    icon: lightbulb
    link: ./demo/ # TODO
    type: primary

  - text: Details
    icon: book
    link: ./guide/ # TODO

highlights:
  - header: What is Cancer Immunotherapy?
    description: Tumor immunotherapy is known as the hope of conquering cancer, whether it is the PD-1 immune checkpoint inhibitor therapy that has been approved in many cancers, or the adoptive cellular immunotherapy represented by CAR-T, as well as many cancer vaccines in full development, are just the tip of the immunological iceberg.
    image: /assets/image/box.svg # TODO
    bgImage: https://theme-hope-assets.vuejs.press/bg/3-light.svg
    bgImageDark: https://theme-hope-assets.vuejs.press/bg/3-dark.svg

  - header: What is ICCI?
    description: ICCI, short for International Congress of Cancer Immunotherapy, is a global conference that brings together researchers, clinicians, and patients to discuss the latest advances in cancer immunotherapy.
    image: /assets/image/advanced.svg
    bgImage: https://theme-hope-assets.vuejs.press/bg/4-light.svg
    bgImageDark: https://theme-hope-assets.vuejs.press/bg/4-dark.svg
    highlights:
      - title: Authoritative
        icon: landmark
        details: ICCI is the leading international forum for cancer immunotherapy research and clinical trials.

      - title: Historical
        icon: history
        details: ICCI has been held annually since 2019, and it has been a major event for cancer immunotherapy research and clinical trials.

      - title: Inclusive
        icon: hands-holding
        details: ICCI is a comprehensive conference, with a wide range of topics and participants.

  - header: What's New in the 6th?
    image: /assets/image/features.svg
    bgImage: https://theme-hope-assets.vuejs.press/bg/1-light.svg
    bgImageDark: https://theme-hope-assets.vuejs.press/bg/1-dark.svg
    features:
      - title: Largest
        icon: globe
        details: Over 200 participants will attend the conference.

      - title: Public
        icon: user-group
        details: The congress will be public.

      - title: Interactive
        icon: hands-helping
        details: All participants can interact with each other.

      - title: Digital
        icon: microchip
        details: All activities can be recorded and shared.

      - title: Online
        icon: network-wired
        details: The congress will be held both in person and online.

      - title: Sensitive
        icon: user-secret
        details: The information of the patients will be kept confidential.

  - header: Topics
    image: /assets/image/markdown.svg # TODO
    bgImage: https://theme-hope-assets.vuejs.press/bg/2-light.svg
    bgImageDark: https://theme-hope-assets.vuejs.press/bg/2-dark.svg
    bgImageStyle:
      background-repeat: repeat
      background-size: initial
    features:
      - title: Immuno-oncology Biomarkers
        icon: circle-dot

      - title: Next-Generation Cell Therapy
        icon: circle-dot

      - title: Immune checkpoint modulators
        icon: circle-dot

      - title: Cytokine Therapy
        icon: circle-dot

      - title: Neoantigen Targeted Therapy 
        icon: circle-dot

      - title: Emerging Immunotherapy Targets
        icon: circle-dot

      - title: Cellular Models for Immunotherapy
        icon: circle-dot

      - title: Clinically relevant mouse models
        icon: circle-dot

      - title: Application of Nanomaterials in Anti-tumor 
        icon: circle-dot

      - title: Immunotherapy Application of Artificial Intelligence and Big Data in Tumor Immunotherapy
        icon: circle-dot

      - title: Investments in Immuno-Oncology
        icon: circle-dot

      - title: Clinical Skills Training in Immuno-Oncology Therapy
        icon: circle-dot

  - header: Participants
    # description: An awesome responsive layout with full a11y support.
    image: /assets/image/layout.svg
    bgImage: https://theme-hope-assets.vuejs.press/bg/5-light.svg
    bgImageDark: https://theme-hope-assets.vuejs.press/bg/5-dark.svg
    highlights:
      - title: Guodong Zhang
        icon: user-doctor
        details: Senior Researcher
        link: https://github.com/zhang-guodong

      - title: Yingying Cao
        icon: user-graduate
        details: Graduate student at Jiangsu University
        link: https://github.com/zhang-guodong

      - title: Meiying Zhang
        icon: user-nurse
        details: Postdoctoral researcher at Jiangsu University
        link: https://github.com/zhang-guodong

  - header: Scan the QR code to join us!
    image: /qrcode.png # /assets/image/blog.svg
    bgImage: https://theme-hope-assets.vuejs.press/bg/6-light.svg
    bgImageDark: https://theme-hope-assets.vuejs.press/bg/6-dark.svg

copyright: false
footer: Theme by <a href="https://theme-hope.vuejs.press/" target="_blank">VuePress Theme Hope</a> | MIT Licensed, Copyright © 2019-2024 Guodong Zhang
---
